Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification
China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received...
SHA: 688289
Sansure Biotech Wins NMPA Approval for Fungal Infection Detection Kit
China’s National Medical Products Administration (NMPA) has approved Sansure Biotech Inc.’s (SHA: 688289) Pneumocystis jirovecii,...
GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation
Shenzhen-based DNA sequencer specialist GeneMind Biosciences Co., Ltd. has reportedly secured RMB 280 million (USD...
Fapon Biotech Partners with Sansure to Develop Next-Generation Diagnostic Solutions
China-based biotech Fapon Biotech Inc. has formed a strategic partnership with molecular diagnostics specialist Sansure...
Sansure Biotech Plans RMB130 Million Investment in Shenzhen GeneMind for Gene Sequencing Expansion
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) announced plans to invest RMB130 million...
Sansure Biotech to Acquire Sinobioway Hygene for $110M to Boost Product Pipeline
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced plans to acquire 100%...
Sansure Biotech’s HPV Detection Kit Receives NMPA Approval for Comprehensive Screening
Sansure Biotech Inc., a molecular diagnostics specialist based in China and listed on the Shanghai...
Sansure Biotech Wins NMPA Nod for ALDH2 Gene Polymorphism Detection Kit
Sansure Biotech Inc., (SHA: 688289), a leading molecular diagnostics company based in China, has announced...
China’s Sansure Biotech Launches Approved Kit for Alzheimer’s and Cardiovascular Risk Assessment
Sansure Biotech Inc. (SHA: 688289), a China-based leader in molecular diagnostics, has secured marketing approval...
Sansure Biotech’s MTHFR Gene Detection Kit Receives NMPA Approval, Aids in Pregnancy Health Management
Sansure Biotech Inc. (SHA: 688289), a specialist in molecular diagnostics based in China, has achieved...
Sansure Biotech’s Tuberculosis Detection Kit Gains CE IVDR Certification for EU Market
Sansure Biotech Inc. (SHA: 688289), a leading molecular diagnostics company based in China, has announced...
Sansure Biotech’s HBV RNA Detection Kit Receives NMPA Marketing Approval
Sansure Biotech Inc., (SHA: 688289), a leading molecular diagnostics company based in China, has announced...
Sansure Biotech Secures CE IVDR Certifications for Chemiluminescence Analyzers in the EU
China-based molecular diagnostics specialist, Sansure Biotech Inc., (SHA: 688289), has announced that it has received...
Sansure Biotech Partners with Shaanxi Lifegen to Boost Molecular Diagnostics
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has formed a strategic partnership with...
Sansure Biotech Secures CE Mark for 60 Molecular Diagnostic Products, Including Procalcitonin Assay Kit
Sansure Biotech Inc., a leading molecular diagnostics specialist based in China (SHA: 688289), has announced...
Sansure Biotech Partners with Indonesian Firm for Localized Molecular Diagnostic Production
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
Sansure Biotech Partners with Shanghai Tenth People’s Hospital for Genomics Center
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has struck a partnership with Shanghai...
Sansure Biotech Partners with Hunan Normal University for Research and Talent Development
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
Sansure Biotech’s Pertussis Detection Kit Approved by NMPA
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) announced that it has obtained medical...
Sansure Biotech Partners with UBC to Manufacture in Indonesia
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has entered into a local manufacturing...